About the research
Can a GP-led model of diabetes care, supported by specialists and diabetes educators, work under real rural conditions?
eCARE — Enhanced Care through Case Conferencing and Remote Engagement — is a NSW Health funded translational research trial. It tests whether a diabetes optimisation model developed over a decade by Western Sydney Diabetes can be translated and sustained in Western NSW, delivered through general practices rather than around them. It is time-limited, not a new routine service: the point is to generate the evidence for future decisions about scale and recurrent funding.
The rural NSW context
Rural and regional NSW has capable general practice teams and a high level of diabetes need, with limited local specialist support to draw on. Three constraints, all structural:
Too few specialists
Expertise has to be shared with general practice differently, because there are not enough rural endocrinologists to see everyone.
Fragmented care
Episodic referrals and disconnected consultations leave little room for preparation, shared decisions or follow-up.
Funding that fights it
Team-based chronic disease care takes time and coordination that current arrangements barely pay for.
Who you would be working with

Prof. Glen Maberly
Endocrinologist · Coordinating Principal Investigator
Endocrinologist and director of Western Sydney Diabetes, leading the eCARE program and chairing its clinical safety oversight.

Dr Rajini Jayaballa
Endocrinologist · Investigator
Endocrinologist with Western Sydney Diabetes, providing specialist input to case conferences and clinical guidance for participating practices.

Prof. Ted Wu
Endocrinologist · MetaDiab
Provides specialist case-conference support and clinical expertise to GP teams taking part in eCARE.

Prof. Jencia Wong
Endocrinologist · Investigator, MetaDiab
Senior endocrinologist bringing specialist diabetes expertise to eCARE's case conferencing and provider education.
Study design
A cluster-randomised, stepped-wedge trial running over 18 months, opening with an eight-week phased implementation period in which practices complete Good Clinical Practice and protocol training. The design allows outcomes to be compared over time without a parallel control group — and without displacing existing services.
12
general practices taking part
~20
participants per practice
18
months, four stepped groups
HbA1c
primary outcome measure
How the trial rolls out
eCARE uses a stepped-wedge design: practices are grouped and each group starts the intervention at a different point, 8 weeks apart. Every practice ends up receiving the full intervention — none miss out.
The intervention: a three-phase care package
Structured, time-limited and focused on skill transfer — anchored throughout in the GP–patient relationship.
Phase 1
Preparation and activation
Structured referral, pathology, short-term CGM, app onboarding and clarification of patient priorities. The first case conference is booked within the first eight weeks.
Phase 2 · 0–4 months
Case conferencing and optimisation
GP-led virtual case conferencing with endocrinologist and diabetes educator input, supported by intermittent CGM and digital coaching, with as many touchpoints as the patient needs.
Phase 3 · 4–6 months
Consolidation and transition
Follow-up conferences and, with the Western Diabetes Hub and the GP, a co-developed transition plan ensuring a supported return to routine GP-led management.
What the trial measures
Patient outcomes
- HbA1c, glucose, lipids and kidney measures
- Quality of life and diabetes distress
- BMI, blood pressure and medications
- Hospital and healthcare use
Practice outcomes
- Case conference, CGM and Diabetes Together uptake
- Diabetes-care and screening indicators
- Practice-level HbA1c
- Team capability and confidence
Qualitative evaluation
- Interviews with patients, GPs, staff and partners
- Implementation and acceptability
- Cultural safety and local leadership
- Led by the Sydney Health Literacy Lab, University of Sydney
Economic evaluation
- Implementation cost
- Cost-effectiveness
- Healthcare utilisation
- Whether reimbursement levels sustain participation
The evidence so far
Three steps: the model was tested and published in Western Sydney, then trialled informally across Western NSW, and is now being evaluated formally here.
It worked in Western Sydney, and the results are published
A retrospective cohort study of 103 people with type 2 diabetes who went through virtual case conferencing with CGM found average HbA1c fell from 9.6% to 8.2% (a 1.4 point reduction, 95% CI 1.03–1.82, P<.001), time in range rose from 46% to 73% (P<.001), and the glucose management indicator improved from 7.9% to 7.0% (P<.001) — all within three to four months. Total daily insulin dose did not change significantly, indicating more targeted management rather than simply more medication.
Mahfuza U, Meyerowitz-Katz G, Rasheed RA, Dick H, Maberly G, Jayaballa R. Digital innovation and integrated care in people with diabetes in Western Sydney: retrospective cohort study. JMIR Diabetes 2025;10:e64832. doi:10.2196/64832
Western NSW clinicians have already tried it
A year of staged orientation with the Western NSW Local Health District and Primary Health Network preceded the trial: preparatory case conferencing with about ten practices and forty patients, which shaped the design, and a Dubbo Masterclass in June 2024 with Care Partnership – Diabetes and MetaDiab attended by around 120 clinicians. Feedback was consistently positive, and a follow-up Masterclass is planned.
Now it is being tested properly, here
eCARE does not assume the Western Sydney results will simply repeat. This trial measures how well a model proven in a metropolitan setting translates to rural and regional general practice, under real workforce and funding constraints — which is the only evidence that will persuade government to fund it permanently.
Safety, ethics and data
eCARE is approved by the Greater Western Human Research Ethics Committee. A clinical reporting committee of senior investigators oversees adverse events, and practices report any serious adverse event to the study team within 24 hours.
All study data is held securely in REDCap, a NSW Health approved system, with regular data quality checks. Findings are reported in aggregate, with no identifiable patient information.
Partners and contributors
eCARE depends on shared stewardship across Western Sydney Diabetes, WNSWLHD, the Western Diabetes Hub, Care Partnership – Diabetes, MetaDiab, the University of Sydney, private endocrinologists and participating general practices.
Funding, and the question behind the question
Funded through a NSW Health Translational Research Grant and delivered with WNSWLHD and WNSW PHN, eCARE runs on a mixed funding model: MBS items, targeted reimbursements, public sector educator support, and industry-supported education, digital tools and CGM. Whether those levels are enough to sustain participation is itself an evaluation question — because a model that only works while a grant is running is not a model the system can adopt.
The trial is equally a test of whether the model builds lasting capability in the practice team — capability that should outlast the funding, and the trial itself.
